疾病性无力、多神经病与肌病:诊断、治疗及长期结局
本叙述性综述总结疾病性无力(CIW)的最新科学进展,并提出从ICU到社区各阶段的诊断与管理指南。CIW表现为ICU入院后弥漫性、对称性无力,认知功能正常的患者可通过床旁徒手肌力测试诊断,应常规进行至ICU出院。谵妄、昏迷或长期严重无力者推荐神经电生理检查,部分病例可行肌肉活检,以区分危重病多神经病与肌病(两者常共存)。CIW与长期躯体、认知和精神损害相关,强调多学科照护模式的必要性,幸存者随访门诊可提供临床支持、转诊管理和研究平台。
要点
- CIW表现为ICU入院后弥漫性、对称性无力,是与非对称性肌无力或瘫痪的其他疾病鉴别的重要特征。
- 认知功能正常的患者可在床旁用徒手肌力测试诊断CIW,应常规进行至ICU出院。
- 谵妄、昏迷或长期严重无力者推荐神经电生理检查,部分病例可行肌肉活检,以区分危重病多神经病或肌病,两者常共存。
- 呼吸肌无力可导致神经肌肉性呼吸衰竭,需及时识别和快速处理以避免危及生命的情况。
- 早期ICU活动联合最佳循证ICU实践可有效减少短期无力;CIW与长期躯体、认知和精神损害相关,需多学科照护模式。
适用人群与场景
- ICU入院后出现弥漫性、对称性无力的重症患者,从ICU到社区各阶段。
- 普通病房中既往ICU治疗时间较长或新发脓毒症的患者。
- 认知功能正常的患者可床旁评估;谵妄、昏迷或长期严重无力者需进一步检查。
诊断标准与关键阈值
- CIW的诊断依据为ICU入院后出现的弥漫性、对称性无力,以此与其他引起非对称性肌无力或瘫痪的疾病鉴别。
- 认知功能正常者采用床旁徒手肌力测试诊断,应常规进行至ICU出院。
处置流程与药物剂量
- 认知功能正常者行床旁徒手肌力测试,常规进行至ICU出院。
- 谵妄、昏迷或长期严重无力者推荐神经电生理检查,部分病例行肌肉活检以区分危重病多神经病或肌病。
- 呼吸肌无力导致神经肌肉性呼吸衰竭时需及时识别和快速处理。
- 积极康复应重新评估并根据患者新情况个体化调整,以降低疾病进展风险。
- 所有ICU幸存者应纵向评估营养状态,并纳入由营养师指导的以患者为中心的营养方案。
- 随访门诊应评估日常生活活动能力、情绪和功能性活动能力。
红旗征与不能漏的情况
- 呼吸肌无力可导致神经肌肉性呼吸衰竭,需及时识别和快速处理以避免危及生命的情况。
- 普通病房中既往ICU治疗时间较长或新发脓毒症的患者可出现CIW。
研究设计与关键结果
- 本叙述性综述总结CIW的最新科学见解,并提出从ICU到社区各阶段优化诊断与管理的临床指南。
- CIW与长期躯体、认知和精神损害相关,强调需要多学科照护模式。
- 危重病幸存者随访门诊可提供直接临床支持、管理向其他专科医生和全科医生的转诊,并作为描述重症后综合征自然史和识别新治疗干预的研究平台。
证据类型、等级与局限
- 证据类型:叙述性综述。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者提出,认知功能正常的患者可在床旁用徒手肌力测试诊断CIW,应常规进行至ICU出院。
- 作者提出,谵妄、昏迷或长期严重无力者推荐神经电生理检查,部分病例行肌肉活检。
- 作者提出,呼吸肌无力导致神经肌肉性呼吸衰竭时需及时识别和快速处理。
- 作者提出,积极康复应重新评估并根据患者新情况个体化调整。
- 作者提出,所有ICU幸存者应纵向评估营养状态并纳入营养师指导的营养方案;随访应评估日常生活活动能力、情绪和功能性活动能力。
- 作者认为,早期ICU活动联合最佳循证ICU实践可有效减少短期无力,需要多专业合作以保证多维度评估和统一的社区照护方案。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: Severe weakness associated with critical illness (CIW) is common. This narrative review summarizes the latest scientific insights and proposes a guide for clinicians to optimize the diagnosis and management of the CIW during the various stages of the disease from the ICU to the community stage.
MAIN BODY: CIW arises as diffuse, symmetrical weakness after ICU admission, which is an important differentiating factor from other diseases causing non-symmetrical muscle weakness or paralysis. In patients with adequate cognitive function, CIW can be easily diagnosed at the bedside using manual muscle testing, which should be routinely conducted until ICU discharge. In patients with delirium or coma or those with prolonged, severe weakness, specific neurophysiological investigations and, in selected cases, muscle biopsy are recommended. With these exams, CIW can be differentiated into critical illness polyneuropathy or myopathy, which often coexist. On the general ward, CIW is seen in patients with prolonged previous ICU treatment, or in those developing a new sepsis. Respiratory muscle weakness can cause neuromuscular respiratory failure, which needs prompt recognition and rapid treatment to avoid life-threatening situations. Active rehabilitation should be reassessed and tailored to the new patient's condition to reduce the risk of disease progression. CIW is associated with long-term physical, cognitive and mental impairments, which emphasizes the need for a multidisciplinary model of care. Follow-up clinics for patients surviving critical illness may serve this purpose by providing direct clinical support to patients, managing referrals to other specialists and general practitioners, and serving as a platform for research to describe the natural history of post-intensive care syndrome and to identify new therapeutic interventions. This surveillance should include an assessment of the activities of daily living, mood, and functional mobility. Finally, nutritional status should be longitudinally assessed in all ICU survivors and incorporated into a patient-centered nutritional approach guided by a dietician.
CONCLUSIONS: Early ICU mobilization combined with the best evidence-based ICU practices can effectively reduce short-term weakness. Multi-professional collaborations are needed to guarantee a multi-dimensional evaluation and unitary community care programs for survivors of critical illnesses.
参考来源
- Latronico N, Rasulo FA, Eikermann M, et al. Illness Weakness, Polyneuropathy and Myopathy: Diagnosis, treatment, and long-term outcomes. Crit Care. 2023. PMID: 37957759. doi:10.1186/s13054-023-04676-3
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。